Charles A K, Brown K W, Berry P J
Department of Pediatric Pathology, St. Michael's Hospital, Bristol, United Kingdom.
Am J Pathol. 1998 Sep;153(3):991-1000. doi: 10.1016/S0002-9440(10)65641-6.
Nephrogenic rests are precursor lesions associated with about 40% of Wilms' tumors. This study identifies genetic steps occurring in the development of Wilms' tumor. Thirty-four Wilms' tumors with nephrogenic rests and/or areas of anaplasia were microdissected from paraffin sections to determine whether and at what stage loss of heterozygosity (LOH) occurred, using polymerase chain reaction-based polymorphic markers at 11p13, 11p15, and 16q. LOH at these loci have been identified in Wilms' tumors and are associated with identified or putative tumor suppressor genes. Three cystic nephromas/cystic partially differentiated nephroblastomas were also examined. LOH was detected in six cases at 11p13 and in six cases at 11p15, and two of these cases had LOH at both loci. All intralobar rests showing LOH also showed LOH in the tumor. A case with a small perilobar rest showed LOH of 11p13 only in the tumor. Five cases showing LOH at 16q were identified (this was identified only in the tumor, and not in the associated rest), and three of these had recurrence of the tumor. Two cases had a WT1 mutation (one germline and the other somatic), as well as LOH in both the intralobar rest and the tumor. A cystic partially differentiated nephroblastoma showed loss at 11p13 and 11p15, as well as at 16q. This study suggests that LOH at 11p13 and 11p15 and WT1 mutations are early events but that LOH at 16q occurs late in the pathogenesis of Wilms' tumor. Intralobar and perilobar nephrogenic rests are known to have different biological behaviors, and this study suggests that they are genetically different. A multistep model of Wilms' tumor pathogenesis is supported by these findings.
肾源性残留是与约40%的肾母细胞瘤相关的前驱病变。本研究确定了肾母细胞瘤发生过程中的基因变化步骤。从石蜡切片中显微切割出34例伴有肾源性残留和/或间变区域的肾母细胞瘤,使用基于聚合酶链反应的位于11p13、11p15和16q的多态性标记,以确定杂合性缺失(LOH)是否发生以及在哪个阶段发生。这些位点的LOH已在肾母细胞瘤中被发现,并与已确定或推测的肿瘤抑制基因相关。还检查了3例囊性肾瘤/囊性部分分化型肾母细胞瘤。在6例中检测到11p13的LOH,在6例中检测到11p15的LOH,其中2例在两个位点均有LOH。所有显示LOH的叶内残留瘤在肿瘤中也显示LOH。1例伴有小叶旁小残留瘤的病例仅在肿瘤中显示11p13的LOH。鉴定出5例16q显示LOH的病例(仅在肿瘤中鉴定出,而不在相关残留瘤中),其中3例肿瘤复发。2例有WT1突变(1例为种系突变,另1例为体细胞突变),在叶内残留瘤和肿瘤中均有LOH。1例囊性部分分化型肾母细胞瘤在11p13、11p15以及16q均显示缺失。本研究提示,11p13和11p15的LOH以及WT1突变是早期事件,但16q的LOH发生在肾母细胞瘤发病机制的晚期。已知叶内和小叶旁肾源性残留具有不同的生物学行为,本研究提示它们在基因上也存在差异。这些发现支持了肾母细胞瘤发病机制的多步骤模型。